Physician profile
Roberto E Solis
NPI 1477556900
$6,397.22
in general payments reported to CMS, 2019-2025
28 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $685 · 2020: $798 · 2021: $648 · 2022: $1,756 · 2023: $1,218 · 2024: $1,078 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,372 · Education: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,371.87 |
| Education | $137.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,049.66 | 2021-2025 | Corevalve Evolut R, Hawkone, Onyx Frontier |
| Amgen INC. | $1,025.29 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $707.20 | 2021-2025 | Jeti All In One Non-Sterile Kit, Coroflow, Diamondback Coronary |
| Astrazeneca Pharmaceuticals LP | $517.14 | 2019-2023 | Brilinta, Farxiga |
| Philips North America LLC | $365.73 | 2019-2025 | Laser Serv and Other Undivided, Philips Laser System |
| Pfizer INC. | $235.05 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $204.10 | 2023-2025 | |
| Boston Scientific Corporation | $187.36 | 2019-2023 | |
| Medtronic Vascular, INC. | $150.37 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $122.76 | 2019-2022 | |
| Endologix LLC | $121.66 | 2024 | Torus Stent Graft System, Endocross Device |
| Sanofi-Aventis U.S. LLC | $96.38 | 2019-2021 | |
| Cordis US Corp. | $91.66 | 2023-2025 | Precise Pro Rx, Saber, Infiniti |
| E.R. Squibb & Sons, L.L.C. | $80.54 | 2021-2024 | Camzyos |
| Amarin Pharma, INC. | $74.84 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $72.24 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Shockwave Medical, INC | $58.79 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $35.65 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.08 | 2021-2024 | Jardiance |
| Gilead Sciences, INC. | $29.67 | 2019 | |
| Acist Medical Systems, INC. | $29.46 | 2022 | |
| Daiichi Sankyo INC. | $25.08 | 2023 | Injectafer |
| Surmodics, INC. | $21.23 | 2024 | Pounce Venous Thrombectomy System |
| Actelion Pharmaceuticals US, INC. | $18.63 | 2019 | |
| Cardinal Health 200 LLC | $16.62 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.91 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.99 | 2020 | |
| Bardy Diagnostics, INC. | $6.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Solis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.